Published in Am J Physiol Lung Cell Mol Physiol on March 23, 2007
Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol (2009) 3.13
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol (2008) 2.58
Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med (2008) 1.62
Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses (2015) 1.43
A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation. PLoS One (2011) 1.34
Proteases and cystic fibrosis. Int J Biochem Cell Biol (2008) 1.25
Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. J Orthop Trauma (2010) 1.24
The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol (2009) 1.21
Assessment of the CFTR and ENaC association. Mol Biosyst (2008) 1.19
Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One (2009) 1.14
Vitamin D deficiency and chronic lung disease. Can Respir J (2009) 1.11
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen. J Neuroimmunol (2009) 1.09
Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation. Nat Chem Biol (2009) 1.07
Peroxisome proliferator-activated receptor-gamma in cystic fibrosis lung epithelium. Am J Physiol Lung Cell Mol Physiol (2008) 1.03
Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci (2008) 1.01
Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther (2008) 0.99
Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol Med (2010) 0.97
Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation. Open Respir Med J (2010) 0.96
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res (2013) 0.91
The role of matrix metalloproteinases in cystic fibrosis lung disease. Eur Respir J (2011) 0.91
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. Sci Rep (2016) 0.90
MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. PLoS One (2012) 0.89
Interfering with extracellular matrix degradation to blunt inflammation. Curr Opin Pharmacol (2008) 0.87
Doxycycline blocks gastric ulcer by regulating matrix metalloproteinase-2 activity and oxidative stress. World J Gastroenterol (2011) 0.86
Antiproteases as therapeutics to target inflammation in cystic fibrosis. Open Respir Med J (2010) 0.84
Pulmonary matrix metalloproteinase-9 activity in mechanically ventilated children with respiratory syncytial virus. Eur Respir J (2013) 0.83
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease. PLoS One (2014) 0.81
Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia. J Infect (2009) 0.80
CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of lyme arthritis. Am J Pathol (2011) 0.79
The matrikine PGP as a potential biomarker in COPD. Am J Physiol Lung Cell Mol Physiol (2015) 0.78
Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis. J Cyst Fibros (2013) 0.78
Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy. Mediators Inflamm (2015) 0.76
Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency. Ann Am Thorac Soc (2016) 0.75
Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma. Inflammation (2016) 0.75
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med (2010) 6.23
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain. Science (2007) 3.96
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol (2008) 2.58
Regulation of chloride channels by protein kinase C in normal and cystic fibrosis airway epithelia. Science (1989) 2.46
Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int (2012) 2.42
Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med (1997) 2.24
Corticotropin-releasing activity of monokines. Science (1985) 2.24
CFTR chloride channel regulation by an interdomain interaction. Science (1999) 2.09
Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J Physiol (2005) 1.97
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med (2013) 1.93
Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85
A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med (2014) 1.85
Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem Biophys Res Commun (1984) 1.77
Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci U S A (1985) 1.75
Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol (2003) 1.71
Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. Nature (1986) 1.65
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One (2012) 1.64
Potential role of high-mobility group box 1 in cystic fibrosis airway disease. Am J Respir Crit Care Med (2008) 1.62
Endorectal repair of rectocele revisited. Br J Surg (1997) 1.57
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One (2013) 1.56
Nonsensitized lymphocytes produce leukocyte interferon when cultured with foreign cells. Cell Immunol (1979) 1.51
A(2) adenosine receptors regulate CFTR through PKA and PLA(2). Am J Physiol Lung Cell Mol Physiol (2002) 1.51
Cloning and direct sequencing from lambda cDNA libraries using the polymerase chain reaction: suppressin and the vasopressin receptor as models. Neth J Med (1991) 1.49
Human lymphocyte production of corticotropin and endorphin-like substances: association with leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.49
cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother (2005) 1.48
Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci U S A (1982) 1.44
Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr (2002) 1.44
Cystic fibrosis transmembrane conductance regulator facilitates ATP release by stimulating a separate ATP release channel for autocrine control of cell volume regulation. J Biol Chem (2000) 1.40
Correlation of the Care by Design primary care practice redesign model and the principles of the patient-centered medical home. J Am Board Fam Med (2012) 1.38
Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. Science (1982) 1.35
Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal. J Biol Chem (1999) 1.35
microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep (2011) 1.34
Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am J Pathol (2008) 1.33
Activation of airway cl- secretion in human subjects by adenosine. Am J Respir Cell Mol Biol (2004) 1.32
Interferon-induced transfer of viral resistance between animal cells. Nature (1977) 1.31
The immune system as a sensory organ. J Immunol (1984) 1.30
Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. Biochem Biophys Res Commun (1985) 1.27
Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One (2012) 1.27
In vivo immunoreactive adrenocorticotropin (ACTH) production by human mononuclear leukocytes from normal and ACTH-deficient individuals. J Clin Endocrinol Metab (1987) 1.17
Calcium influx factor is synthesized by yeast and mammalian cells depleted of organellar calcium stores. Proc Natl Acad Sci U S A (1999) 1.17
Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. Proc Natl Acad Sci U S A (1980) 1.16
DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther (2010) 1.16
Binding of peptides that are specified by complementary RNAs. Biochem J (1986) 1.16
Survival after shock requiring high-dose vasopressor therapy. Chest (2013) 1.15
Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc Natl Acad Sci U S A (1986) 1.15
A dynamic model for genome-wide association studies. Hum Genet (2011) 1.15
Interactions between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev (1987) 1.12
Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci U S A (1986) 1.12
Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry. J Biol Chem (2003) 1.12
Common pathways of interferon and hormonal action. Nature (1980) 1.10
Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol (2007) 1.10
Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue. Am J Respir Cell Mol Biol (2009) 1.07
Genetic and reproductive knowledge among adolescents and adults with cystic fibrosis. Chest (2008) 1.07
DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur J Hum Genet (2006) 1.06
Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer. PLoS One (2013) 1.06
Dazl promotes germ cell differentiation from embryonic stem cells. J Mol Cell Biol (2009) 1.05
Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol (1984) 1.05
Androgen-responsive gene database: integrated knowledge on androgen-responsive genes. Mol Endocrinol (2009) 1.04
Effectiveness of an HIV/AIDS educational programme for Chinese nurses. J Adv Nurs (2006) 1.04
Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol (1978) 1.04
A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther (2001) 1.04
Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol (1989) 1.04
Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc Natl Acad Sci U S A (1988) 1.04
MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell (2012) 1.04
Generation of a soluble IFN-gamma inducer by oxidation of galactose residues on macrophages. Cell Immunol (1985) 1.03
Human lymphocyte production of immunoreactive thyrotropin. Proc Natl Acad Sci U S A (1983) 1.03
Screening genetically modified organisms using multiplex-PCR coupled with oligonucleotide microarray. Biosens Bioelectron (2006) 1.03
Peptide hormones shared by the neuroendocrine and immunologic systems. J Immunol (1985) 1.02
Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet (2006) 1.02
Human B lymphocytes produce leukocyte interferon after interaction with foreign cells. Infect Immun (1981) 1.02
Cloning and identification of a novel human gene PDLIM5, a homolog of AD-associated neuronal thread protein (AD7c-NTP). DNA Seq (2004) 1.02
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci (2008) 1.01
Mutations in the amino terminus of the cystic fibrosis transmembrane conductance regulator enhance endocytosis. J Biol Chem (2005) 1.01
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis. Am J Respir Cell Mol Biol (2014) 1.01
Laser speckle contrast imaging of cerebral blood flow in freely moving animals. J Biomed Opt (2011) 1.00
An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol (1986) 1.00
MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol Cell Biochem (2013) 0.99
Cell-produced viral inhibitor: possible mechanism of action and chemical composition. Infect Immun (1981) 0.99
Molecular characterization of a corticotropin (ACTH) receptor. Mol Cell Endocrinol (1986) 0.98
Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea. Invest Ophthalmol Vis Sci (2001) 0.98
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatr Pulmonol (2011) 0.98
An analysis of the binding of repressor protein ModE to modABCD (molybdate transport) operator/promoter DNA of Escherichia coli. J Biol Chem (1999) 0.98
A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk. J Hum Genet (2007) 0.98
Immune-type interferon-induced transfer of viral resistance. J Immunol (1979) 0.97
Molecular cloning, sequence analysis, expression, and tissue distribution of suppressin, a novel suppressor of cell cycle entry. J Biol Chem (1998) 0.97
Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science (1988) 0.97
Event-specific detection of seven genetically modified soybean and maizes using multiplex-PCR coupled with oligonucleotide microarray. J Agric Food Chem (2007) 0.97
Thyrotropin: an endogenous regulator of the in vitro immune response. J Immunol (1989) 0.97
Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J (1988) 0.96
Interleukin 1 and interleukin 2 enhance proopiomelanocortin gene expression in pituitary cells. J Immunol (1987) 0.96
Retinoic acid and the restoration of anchorage dependent growth to transformed mammalian cells. Exp Cell Res (1978) 0.96
Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem Biophys Res Commun (1981) 0.96
Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol Pharm (2014) 0.95
Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. PLoS One (2013) 0.95
RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. World J Gastroenterol (2002) 0.95